...
首页> 外文期刊>The journals of gerontology.Series A. Biological sciences and medical sciences >Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people.
【24h】

Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people.

机译:针对社区居住的脆弱老年人的多学科干预模型的成本效益。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: There is growing interest in geriatric care for community-dwelling older people. There are, however, relatively few reports on the economics of this type of care. This article reports about the cost-effectiveness of the Dutch Geriatric Intervention Program (DGIP) compared to usual care in frail older people at 6-month follow-up from a health care system's point of view. METHODS: We conducted this economic evaluation in an observer-blind randomized controlled trial (Dutch EASYcare Study: ClinicalTrials.gov Identifier NCT00105378). Difference in treatment effect was calculated as the difference in proportions of successfully treated patients (prevented functional decline accompanied by improved well-being). Incremental treatment costs were calculated as the difference in mean total care costs. The incremental cost-effectiveness ratio (ICER) was expressed as total cost per successful treatment. Bootstrap methods were used to determine confidence intervals (CI) for these measures. RESULTS: The average cost of the intervention under study (DGIP) was 998 euros (95% CI, 888-1108). The increment in total cost resulting from DGIP was a little over 761 euros (-3336 to 4687). Hospitalization and institutionalization costs were less; home care, adult day care, and meals-on-wheels costs were higher. There was a significant difference in proportions of successful treatments of 22.3% (4.3-41.4). The number needed to treat was approximately 4.7 (2.3-18.0). The ICER is 3418 euros per successful treatment (-21,458 to 45,362). The new treatment is cost-effective at a willingness-to-pay of 34,000 euros. CONCLUSION: The results of this economic evaluation suggest that DGIP is an effective addition to primary care for frail older people at a reasonable cost.
机译:背景:对社区居民老年人的老年保健越来越感兴趣。但是,关于这种护理的经济学报道相对较少。本文从医疗保健系统的角度报告了在六个月的随访中,荷兰老年医学干预计划(DGIP)与体弱老年人的常规护理相比的成本效益。方法:我们在一项观察者盲的随机对照试验(荷兰EASYcare研究:ClinicalTrials.gov标识符NCT00105378)中进行了这项经济评估。将治疗效果的差异计算为成功治疗的患者比例的差异(预防的功能下降伴随改善的幸福感)。计算的增量治疗费用为平均总护理费用之差。成本效益比增量(ICER)表示为每次成功治疗的总成本。自举方法用于确定这些度量的置信区间(CI)。结果:研究中的干预措施(DGIP)的平均费用为998欧元(95%CI,888-1108)。 DGIP导致的总成本增加了761欧元(-3336至4687)。住院和住院费用较低;家庭护理,成人日托和随车用餐费用更高。成功治疗的比例有22.3%(4.3-41.4)的显着差异。需要治疗的人数约为4.7(2.3-18.0)。每成功的治疗,ICER为3418欧元(-21,458至45,362)。这种新疗法具有成本效益,愿意支付34,000欧元。结论:这项经济评估的结果表明,DGIP以合理的成本有效地补充了脆弱的老年人的初级保健。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号